These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

748 related items for PubMed ID: 1875966

  • 1. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites.
    Ginès P, Arroyo V, Vargas V, Planas R, Casafont F, Panés J, Hoyos M, Viladomiu L, Rimola A, Morillas R.
    N Engl J Med; 1991 Sep 19; 325(12):829-35. PubMed ID: 1875966
    [Abstract] [Full Text] [Related]

  • 2. Treatment of ascites in cirrhosis. Diuretics, peritoneovenous shunt, and large-volume paracentesis.
    Arroyo V, Ginès P, Planas R.
    Gastroenterol Clin North Am; 1992 Mar 19; 21(1):237-56. PubMed ID: 1568775
    [Abstract] [Full Text] [Related]

  • 3. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites.
    Rössle M, Ochs A, Gülberg V, Siegerstetter V, Holl J, Deibert P, Olschewski M, Reiser M, Gerbes AL.
    N Engl J Med; 2000 Jun 08; 342(23):1701-7. PubMed ID: 10841872
    [Abstract] [Full Text] [Related]

  • 4. Peritoneovenous shunting as compared with medical treatment in patients with alcoholic cirrhosis and massive ascites. Veterans Administration Cooperative Study on Treatment of Alcoholic Cirrhosis with Ascites.
    Stanley MM, Ochi S, Lee KK, Nemchausky BA, Greenlee HB, Allen JI, Allen MJ, Baum RA, Gadacz TR, Camara DS.
    N Engl J Med; 1989 Dec 14; 321(24):1632-8. PubMed ID: 2586565
    [Abstract] [Full Text] [Related]

  • 5. Treatment of patients with cirrhosis and refractory ascites using LeVeen shunt with titanium tip: comparison with therapeutic paracentesis.
    Ginès A, Planas R, Angeli P, Guarner C, Salerno F, Ginès P, Saló J, Rodriguez N, Domènech E, Soriano G.
    Hepatology; 1995 Jul 14; 22(1):124-31. PubMed ID: 7601403
    [Abstract] [Full Text] [Related]

  • 6. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis.
    Ginès P, Uriz J, Calahorra B, Garcia-Tsao G, Kamath PS, Del Arbol LR, Planas R, Bosch J, Arroyo V, Rodés J.
    Gastroenterology; 2002 Dec 14; 123(6):1839-47. PubMed ID: 12454841
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Long-term clinical outcome of large volume paracentesis with intravenous albumin in patients with spontaneous bacterial peritonitis: a randomized prospective study.
    Choi CH, Ahn SH, Kim DY, Lee SK, Park JY, Chon CY, Moon YM, Han KH.
    J Gastroenterol Hepatol; 2005 Aug 14; 20(8):1215-22. PubMed ID: 16048569
    [Abstract] [Full Text] [Related]

  • 9. [Treatment of ascites in patients with liver cirrhosis without neither hyponatremia nor renal insufficiency. Results of a randomized study comparing diuretics and punctures compensated by albumin].
    Hagège H, Ink O, Ducreux M, Pelletier G, Buffet C, Etienne JP.
    Gastroenterol Clin Biol; 1992 Aug 14; 16(10):751-5. PubMed ID: 1478401
    [Abstract] [Full Text] [Related]

  • 10. Treatment of malignant ascites in patients with advanced cancer: peritoneovenous shunt versus paracentesis.
    Seike M, Maetani I, Sakai Y.
    J Gastroenterol Hepatol; 2007 Dec 14; 22(12):2161-6. PubMed ID: 18031375
    [Abstract] [Full Text] [Related]

  • 11. [Paracentesis combined with albumin infusion in the treatment of tense ascites in cirrhotic patients].
    Chesta J, Brahm J, Latorre R, Gidi J, Hurtado C, Antezana C, Novoa X, Velasco M.
    Rev Med Chil; 1990 Aug 14; 118(8):874-80. PubMed ID: 2152231
    [Abstract] [Full Text] [Related]

  • 12. [Old method reevaluated. Paracentesis is effective and safe in the treatment of ascites in patients with liver cirrhosis].
    Johansson A, Eriksson LS.
    Lakartidningen; 1992 Jul 08; 89(28-29):2447-50. PubMed ID: 1507965
    [No Abstract] [Full Text] [Related]

  • 13. Clinical Trial: High-dose furosemide plus small-volume hypertonic saline solutions vs. repeated paracentesis as treatment of refractory ascites.
    Licata G, Tuttolomondo A, Licata A, Parrinello G, Di Raimondo D, Di Sciacca R, Cammà C, Craxì A, Paterna S, Pinto A.
    Aliment Pharmacol Ther; 2009 Aug 08; 30(3):227-35. PubMed ID: 19438847
    [Abstract] [Full Text] [Related]

  • 14. Peritoneovenous shunting for malignant ascites.
    Wickremesekera SK, Stubbs RS.
    N Z Med J; 1997 Feb 14; 110(1037):33-5. PubMed ID: 9066565
    [Abstract] [Full Text] [Related]

  • 15. Prevention of paracentesis-induced circulatory dysfunction in cirrhosis: standard vs half albumin doses. A prospective, randomized, unblinded pilot study.
    Alessandria C, Elia C, Mezzabotta L, Risso A, Andrealli A, Spandre M, Morgando A, Marzano A, Rizzetto M.
    Dig Liver Dis; 2011 Nov 14; 43(11):881-6. PubMed ID: 21741331
    [Abstract] [Full Text] [Related]

  • 16. [Peritoneovenous shunting in intractable ascites of cirrhosis. Results of a prospective study on improving prognostic factors].
    Hillaire S, Labianca M, Smadja C, Grange D, Franco D.
    Gastroenterol Clin Biol; 1988 Oct 14; 12(10):681-6. PubMed ID: 3220223
    [Abstract] [Full Text] [Related]

  • 17. Failure of LeVeen shunting in refractory ascites--a view from the other side.
    Grischkan DM, Cooperman AM, Hermann RE, Carey WD, Ferguson DR, Cook SA.
    Surgery; 1981 Mar 14; 89(3):304-8. PubMed ID: 7466618
    [Abstract] [Full Text] [Related]

  • 18. Prospective study comparing human albumin vs. reinfusion of ultrafiltrate-ascitic fluid after total paracentesis in cirrhotic patients with tense ascites.
    Zaak D, Paquet KJ, Kuhn R.
    Z Gastroenterol; 2001 Jan 14; 39(1):5-10. PubMed ID: 11215366
    [Abstract] [Full Text] [Related]

  • 19. Peritoneovenous shunting of intractable ascites in patients with cirrhosis: improving results and predictive factors of failure.
    Hillaire S, Labianca M, Borgonovo G, Smadja C, Grange D, Franco D.
    Surgery; 1993 Apr 14; 113(4):373-9. PubMed ID: 8456392
    [Abstract] [Full Text] [Related]

  • 20. Saphenoperitoneal shunts for patients with intractable ascites associated with chronic liver disease.
    Vadeyar HJ, Doran JD, Charnley R, Ryder SD.
    Br J Surg; 1999 Jul 14; 86(7):882-5. PubMed ID: 10417558
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.